Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Dose of Dexmedetomidine for Skull Pin Fixation
NCT06837818Phase 4Not yet recruiting
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Mar 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in procedural pain, sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Primary endpoints: 50% effect concentration of dexmedetomidine up to 15 minutes and 95% effect concentration of dexmedetomidine up to 15 minutes. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06837818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06837818.